Evidence map›Paper›PMID 27994061›Full record

ArticleThe Journal of biological chemistry2017

Focal Adhesion Kinase-mediated Phosphorylation of Beclin1 Protein Suppresses Cardiomyocyte Autophagy and Initiates Hypertrophic Growth.

Zhaokang Cheng, Qiang Zhu, Rachel Dee, Zachary Opheim, Christopher P Mack, Douglas M Cyr, Joan M Taylor

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Emerging therapeutic targets for cardiac hypertrophy.Expert opinion on therapeutic targets · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Regulation of Beclin 1-Mediated Autophagy by Oncogenic Tyrosine Kinases.International journal of molecular sciences · 2020
    Review
  17. FAK Signaling in Rhabdomyosarcoma.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zhaokang ChengFrom the Department of Pathology.
Qiang ZhuFrom the Department of Pathology.
Rachel DeeFrom the Department of Pathology.
Zachary OpheimFrom the Department of Pathology.
Christopher P MackFrom the Department of Pathology.
Douglas M CyrDepartment of Cell Biology and Physiology, University of North Carolina, Chapel Hill, North Carolina 27599.
Joan M TaylorFrom the Department of Pathology, jmt3x@med.unc.edu.
University of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Pre-doctoral Training Program in Integrative Vascular BiologyT32HL069768 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Christopher P. Mack · 2002 to 2026
$9.7M
Roles for Hsp70 and Hsp40 in Membrane Protein TriageR01GM056981 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CYR, DOUGLAS M · 1998 to 2019
$6.1M
Genetic and epigenetic regulation of vascular smooth muscle cell phenotype and contractilityR01HL109607 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MACK, CHRISTOPHER P. · 2012 to 2022
$3.0M
Role of The Rho-GAP GRAF3 In The Pathogenesis of Human HypertensionR01HL130367 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MACK, CHRISTOPHER P., TAYLOR, JOAN M · 2016 to 2019
$2.9M
FAK Signaling in cardiac growth and hypertrophyR01HL081844 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TAYLOR, JOAN M · 2005 to 2013
$2.6M
Molecular Control of Cardiomyocyte Mitophagy by the RhoGAP GRAF1R01HL142879 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TAYLOR, JOAN M · 2020 to 2023
$1.8M
Promoting chemoresistance in the heartR00HL119605 · NHLBI · WASHINGTON STATE UNIVERSITY · PI CHENG, ZHAOKANG · 2016 to 2018
$747k
NCI NIH HHS P30 CA016086NHLBI NIH HHS R01 HL081844NHLBI NIH HHS R01 HL109607NHLBI NIH HHS R01 HL130367NHLBI NIH HHS R01 HL142879NHLBI NIH HHS T32 HL069768NIGMS NIH HHS R01 GM056981
6 · The paper itself

Abstract

Autophagy is an evolutionarily conserved intracellular degradation/recycling system that is essential for cellular homeostasis but is dysregulated in a number of diseases, including myocardial hypertrophy. Although it is clear that limiting or accelerating autophagic flux can result in pathological cardiac remodeling, the physiological signaling pathways that fine-tune cardiac autophagy are poorly understood. Herein, we demonstrated that stimulation of cardiomyocytes with phenylephrine (PE), a well known hypertrophic agonist, suppresses autophagy and that activation of focal adhesion kinase (FAK) is necessary for PE-stimulated autophagy suppression and subsequent initiation of hypertrophic growth. Mechanistically, we showed that FAK phosphorylates Beclin1, a core autophagy protein, on Tyr-233 and that this post-translational modification limits Beclin1 association with Atg14L and reduces Beclin1-dependent autophagosome formation. Remarkably, although ectopic expression of wild-type Beclin1 promoted cardiomyocyte atrophy, expression of a Y233E phosphomimetic variant of Beclin1 failed to affect cardiomyocyte size. Moreover, genetic depletion of Beclin1 attenuated PE-mediated/FAK-dependent initiation of myocyte hypertrophy

Indexed as

AutophagyAnimalsBeclin-1CardiomegalyFocal Adhesion Protein-Tyrosine KinasesMiceMice, Inbred C57BLMyocytes, CardiacPhosphorylationReceptors, Adrenergic, alphaSignal TransductionBeclin-1Becn1 protein, mouseFocal Adhesion Protein-Tyrosine KinasesReceptors, Adrenergic, alphaatrophyautophagyBeclin-1 (BECN1)cardiac hypertrophymuscle atrophyPTK2 protein tyrosine kinase 2 (PTK2) (focal adhesion kinase) (FAK)

Identifiers

PMID27994061
PMCPMC5313082
OpenAlexW2561882527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.